Latest Information Update: 04 Dec 2006
At a glance
- Originator Japan Tobacco
- Mechanism of Action Aldehyde reductase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Diabetic complications
Most Recent Events
- 04 Jul 2002 Phase-II clinical trials in Diabetic complications in Japan (PO)